1. Home
  2. ZVIA vs GNLX Comparison

ZVIA vs GNLX Comparison

Compare ZVIA & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zevia PBC

ZVIA

Zevia PBC

HOLD

Current Price

$1.50

Market Cap

111.3M

ML Signal

HOLD

Logo Genelux Corporation

GNLX

Genelux Corporation

HOLD

Current Price

$2.98

Market Cap

113.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZVIA
GNLX
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.3M
113.6M
IPO Year
2021
2022

Fundamental Metrics

Financial Performance
Metric
ZVIA
GNLX
Price
$1.50
$2.98
Analyst Decision
Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.93
$17.25
AVG Volume (30 Days)
1.2M
144.8K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
55.88
9.47
EPS
N/A
N/A
Revenue
$161,259,000.00
$8,000.00
Revenue This Year
$8.30
N/A
Revenue Next Year
$6.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
4.01
N/A
52 Week Low
$1.11
$2.29
52 Week High
$3.66
$8.54

Technical Indicators

Market Signals
Indicator
ZVIA
GNLX
Relative Strength Index (RSI) 54.65 53.11
Support Level $1.13 $2.51
Resistance Level $1.53 $3.21
Average True Range (ATR) 0.13 0.15
MACD -0.02 -0.02
Stochastic Oscillator 31.78 46.84

Price Performance

Historical Comparison
ZVIA
GNLX

About ZVIA Zevia PBC

Zevia PBC is a beverage company disrupting the liquid refreshment beverage industry through refreshing, zero-calorie, zero-sugar, naturally sweetened beverages that are all Non-GMO Project Verified. It offers a platform of products that include a variety of flavors across Soda, Energy Drinks, Organic Tea, Mixers, Kidz drinks, and Sparkling Water. Its products are distributed across the U.S. and Canada through a network of retailers in the food, drug, mass, natural, and e-commerce channels. The company derives a majority of its revenue from the United States.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: